Skip to main content
. 2017 Sep 28;8(56):95791–95798. doi: 10.18632/oncotarget.21327

Figure 2.

Figure 2

OS in basaloid A and non-basaloid B subgroups (A); survival probability in relation to follow-up period in months in basaloid subgroup B (B).